Optimizing Afatinib Use: Dosing Strategies and Adverse Event Management
Explore dosing nuances and adverse event management strategies for afatinib in treating EGFR mutant non-small cell lung cancer, reflecting real-world practices and clinical insights.
Precision Medicine Biomarker Testing Afatinib Use Dosing Strategies Adverse Event Non Small Cell Lung Cancer
Source: onclive.com